STVN logo

Stevanato Group SpA (STVN) Company Overview

Profile

Full Name:

Stevanato Group S.p.A.

Sector:

Healthcare

Industry:

Medical Instruments & Supplies

Country:

Italy

IPO:

July 16, 2021

Indexes:

Not included

Website:

http://www.stevanatogroup.com

Description:

STVN, or Stevanato Group SpA, is an Italian company that specializes in manufacturing glass containers and drug delivery systems for the pharmaceutical industry. They provide innovative solutions to ensure safe and effective packaging for medicines, focusing on quality and sustainability in their production processes.

Key Details

Price

$19.05

Market Cap

$5.20 B(Mid cap)

Last Dividend

$0.06

TTM Dividend Yield

0.30%

Annual Revenue

$1.18 B(+13.27% YoY)

Annual EPS

$0.60(+4.55% YoY)

PE Ratio

40.87

Annual ROE

13.59%

Annual Debt To Equity

0.33

Beta

0.29

Events Calendar

Earnings

Next earnings date:

Mar 6, 2025

Recent quarterly earnings:

Nov 5, 2024

Recent annual earnings:

Mar 7, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Jun 4, 2024
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Dec 13, 24 Wolfe Research
Outperform
Dec 13, 24 B of A Securities
Buy
Aug 7, 24 Citigroup
Buy
Jul 15, 24 Morgan Stanley
Equal-Weight
Apr 22, 24 Morgan Stanley
Equal-Weight
Mar 25, 24 Stephens & Co.
Overweight
Nov 1, 23 Morgan Stanley
Equal-Weight
Nov 1, 23 Jefferies
Hold
Sep 26, 23 Stephens & Co.
Overweight
Sep 19, 23 CJS Securities
Market Outperform

Screeners with STVN included

Growing Shares Outstanding
Mid cap stocks
Earnings tomorrow
Earnings this week
Healthcare sector
All stocks
Stocks below SMA 200
Stocks with low beta
Medical Instruments & Supplies industry

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$19.05
STVN price is $19.05

Price All-time High

$35.49
STVN price is currently -46.31% below its historical high of $35.49

Price Analysts Target

-
STVN price consensus analysts' forecast is unknown

Price Today Change

-1.37%
STVN price is down -1.37% today

Price YTD Change

-12.55%
STVN price is down -12.55% since January 1st

Price 3-Year Change

+14.24%
STVN price is up +14.24% over the past 3 years

Market cap

Market Cap

$5.20 B
STVN market capitalization is $5.20 billion

Market Cap 3-Year Change

+17.78%
STVN market capitalization is up +17.78% over the past 3 years

Market Cap All-time High

$9.39 B
STVN market capitalization is currently -44.65% below its historical high of $9.39 billion

Market Cap Sector Rank

88.64%
STVN market capitalization is higher than 88.64% of companies in Healthcare sector

Technical

Beta

0.29
STVN beta is 0.29

200-day SMA

$20.17
STVN price is currently -5.54% below its 200-day simple moving average

14-day RSI

41.77
STVN 14-day relative strength index is 41.77

30-day Relative Volume

0.91
STVN 30-day relative volume is 0.91

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.06
STVN last dividend was $0.06 per share, with an ex-dividend date of June 4, 2024

Next Dividend

-
STVN next dividend has not yet been announced

Dividend per share

Annual Dividend Per Share

$0.06
STVN annual dividend per share is $0.06

Annual Dividend Per Share Sector Rank

1.2%
STVN annual dividend per share is higher than 1.2% of companies in Healthcare sector

Annual Dividend Per Share 1-Year Change

+8.04%
STVN annual dividend per share is up +8.04% year-on-year

Annual Dividend Per Share 3-Year Change

-
STVN annual dividend per share 3-year change is unknown

Dividend yield

Annual Dividend Yield

0.30%
STVN annual dividend yield is 0.30%

Annual Dividend Yield Sector Rank

8.54%
STVN annual dividend yield is higher than 8.54% of companies in Healthcare sector

Other

Annual Payout Ratio

9.82%
STVN annual payout ratio is 9.82%

Annual Dividends Paid

$15.47 M
STVN annual dividends paid is $15.47 million

Annual FCF

-$364.54 M
STVN annual free cash flow is -$364.54 million

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$1.18 B
STVN annual revenue is $1.18 billion

Annual Revenue Analysts Estimate

$1.10 B
STVN annual revenue is currently +7.19% higher than the consensus analysts' forecast

Annual Revenue 1-Year Change

+13.27%
STVN annual revenue is up +13.27% year-on-year

Annual Revenue Sector Rank

82.14%
STVN annual revenue is higher than 82.14% of companies in Healthcare sector

Profit

Annual Gross Profit

$367.97 M
STVN annual gross profit is $367.97 million

Annual Gross Margin

31.32%
STVN annual gross profit margin is 31.32%

Annual Operating Profit

$217.30 M
STVN annual operating income is $217.30 million

Annual Operating Margin

18.49%
STVN annual operating profit margin is 18.49%

Annual Net Income

$157.66 M
STVN annual net profit is $157.66 million

Annual Net Margin

13.42%
STVN annual net profit margin is 13.42%

EPS

Annual EPS

$0.60
STVN annual earnings per share is $0.60

Annual EPS Analysts Estimate

$0.50
STVN annual earnings per share is currently +19.34% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

+4.55%
STVN annual earnings per share is up +4.55% year-on-year

Annual EPS Sector Rank

87.01%
STVN annual earnings per share is higher than 87.01% of companies in Healthcare sector

ROA & ROE

Annual ROA

7.75%
STVN annual return on assets is 7.75%

Annual ROE

13.59%
STVN annual return on equity is 13.59%

EBIT & EBITDA

Annual EBIT

$209.88 M
STVN annual earnings before interest & taxes is $209.88 million

Annual EBITDA

$294.85 M
STVN annual EBITDA is $294.85 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

40.87
STVN price to earnings ratio is 40.87

PE Ratio Sector Rank

69.35%
STVN price to earnings ratio is higher than 69.35% of companies in Healthcare sector

PB Ratio

PB Ratio

3.52
STVN price to book ratio is 3.52

PB Ratio Sector Rank

73.76%
STVN price to book ratio is higher than 73.76% of companies in Healthcare sector

PS Ratio

PS Ratio

4.38
STVN price to sales ratio is 4.38

PS Ratio Sector Rank

58.83%
STVN price to sales ratio is higher than 58.83% of companies in Healthcare sector

Enterprise value

Enterprise Value

$5.52 B
STVN enterprise value is $5.52 billion

Enterprise Value Sector Rank

88.39%
STVN enterprise value is higher than 88.39% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

19.26
STVN EV/EBITDA is 19.26

EV/EBITDA Sector Rank

90.56%
STVN EV/EBITDA is higher than 90.56% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

1.50
STVN annual current ratio is 1.50

Annual Quick Ratio

1.06
STVN annual quick ratio is 1.06

Leverage

Annual Debt To Equity

0.33
STVN annual debt to equity ratio is 0.33

Annual Interest Coverage Ratio

44.93
STVN annual interest coverage ratio is 44.93

Risk & Stability

Piotroski F-Score

5
STVN piotroski f-score is 5

Altman Z-Score

-
STVN altman z-score value is unknown

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$2.29 B
STVN annual total assets is $2.29 billion

Annual Non Current Assets

$1.34 B
STVN annual long term assets is $1.34 billion

Annual Current Assets

$952.74 M
STVN annual total current assets is $952.74 million

Annual Cash & Cash Equivalents

$76.94 M
STVN annual cash & cash equivalents is $76.94 million

Equity

Annual Book Value

$1.25 B
STVN annual book value is $1.25 billion

Annual Working Capital

$317.81 M
STVN annual working capital is $317.81 million

Liabilities

Annual Total Liabilities

$1.04 B
STVN annual total liabilities is $1.04 billion

Annual Total Long Term Liabilities

$402.97 M
STVN annual total long term liabilities is $402.97 million

Annual Current Liabilities

$634.93 M
STVN annual total current liabilities is $634.93 million

Annual Accounts Payable

$307.10 M
STVN annual accounts payable is $307.10 million

Debt

Annual Total Debt

$438.39 M
STVN annual total debt is $438.39 million

Annual Total Debt 1-Year Change

+87.21%
STVN annual total debt is up +87.21% year-on-year

Annual Long Term Debt

$282.04 M
STVN annual long term debt is $282.04 million

Annual Short Term Debt

$156.35 M
STVN annual short term debt is $156.35 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$957.71 M
STVN annual total expenses is $957.71 million

Annual Operating Expenses

$150.67 M
STVN annual total operating expenses is $150.67 million

Annual Cost Of Goods Sold

$807.04 M
STVN annual cost of goods sold is $807.04 million

Annual SGA

$123.34 M
STVN annual SGA is $123.34 million

Annual D&A

$84.96 M
STVN annual depreciation & amortization is $84.96 million

Annual Interest Expense

$4.67 M
STVN annual interest expense is $4.67 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$113.90 M
STVN annual cash flow from operations is $113.90 million

Annual CFO 1-Year Change

+4.54%
STVN annual cash flow from operations is up +4.54% year-on-year

Annual CFI

-$456.02 M
STVN annual cash flow from investing activities is -$456.02 million

Annual CFI 1-Year Change

-77.98%
STVN annual cash flow from investing activities is down -77.98% year-on-year

Annual CFF

$171.08 M
STVN annual cash flow from financing activities is $171.08 million

Annual CFF 1-Year Change

+464.26%
STVN annual cash flow from financing activities is up +464.26% year-on-year

Free CashFlow

Annual FCF

-$364.54 M
STVN annual free cash flow is -$364.54 million

Annual FCF 1-Year Change

-147.23%
STVN annual free cash flow is down -147.23% year-on-year

CAPEX

Annual CAPEX

$478.44 M
STVN annual capital expenditures is $478.44 million

Annual CAPEX 1-Year Change

+86.6%
STVN annual capital expenditures is up +86.6% year-on-year

Institutional Ownership

Similar stocks

GH logo
Guardant Health (GH)
IONS logo
Ionis Pharmaceuticals (IONS)
CYTK logo
Cytokinetics Incorporated (CYTK)
INSP logo
Inspire Medical Systems (INSP)
NUVL logo
Nuvalent (NUVL)
KRYS logo
Krystal Biotech (KRYS)
ELAN logo
Elanco Animal Health Incorporated (ELAN)
BLCO logo
Bausch Lomb (BLCO)
TGTX logo
TG Therapeutics (TGTX)

FAQ

  • What is the ticker symbol for Stevanato Group SpA?
  • Does Stevanato Group SpA pay dividends?
  • What sector is Stevanato Group SpA in?
  • What industry is Stevanato Group SpA in?
  • What country is Stevanato Group SpA based in?
  • When did Stevanato Group SpA go public?
  • Is Stevanato Group SpA in the S&P 500?
  • Is Stevanato Group SpA in the NASDAQ 100?
  • Is Stevanato Group SpA in the Dow Jones?
  • When was Stevanato Group SpA's last earnings report?
  • When does Stevanato Group SpA report earnings?

What is the ticker symbol for Stevanato Group SpA?

The ticker symbol for Stevanato Group SpA is NYSE:STVN

Does Stevanato Group SpA pay dividends?

Yes, Stevanato Group SpA pays dividends. The last payment was $0.06, with an ex-dividend date on June 4, 2024

What sector is Stevanato Group SpA in?

Stevanato Group SpA is in the Healthcare sector

What industry is Stevanato Group SpA in?

Stevanato Group SpA is in the Medical Instruments & Supplies industry

What country is Stevanato Group SpA based in?

Stevanato Group SpA is headquartered in Italy

When did Stevanato Group SpA go public?

Stevanato Group SpA's initial public offering (IPO) was on July 16, 2021

Is Stevanato Group SpA in the S&P 500?

No, Stevanato Group SpA is not included in the S&P 500 index

Is Stevanato Group SpA in the NASDAQ 100?

No, Stevanato Group SpA is not included in the NASDAQ 100 index

Is Stevanato Group SpA in the Dow Jones?

No, Stevanato Group SpA is not included in the Dow Jones index

When was Stevanato Group SpA's last earnings report?

Stevanato Group SpA's most recent earnings report was on Nov 5, 2024

When does Stevanato Group SpA report earnings?

The next expected earnings date for Stevanato Group SpA is Mar 6, 2025